Xue-Ping Yu (Xueping Yu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Alimentary pharmacology & therapeutics

Nature communications

PLoS pathogens

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Xue-Ping Yu, Yijuan Zheng, Da-Wu Zeng, Yongjun Zhou, Jian Sun, Milong Su, Huatang Zhang, Minhui Zheng, Zhipeng Huang, Wenwu Lin, Richeng Mao, Qirong Jiang, Chunfu Zheng, Zhijun Su
Decreased frequency of a novel T-lymphocyte subset, CD3 + CD4 - CD7 + CD57 - T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression. Journal of medical virology (2022)
Feifei Yang, Xue-Ping Yu, Chenliang Zhou, Richeng Mao, Mengqi Zhu, Haoxiang Zhu, Zhenxuan Ma, Bidisha Mitra, Gan Zhao, Yuxian Huang, Haitao Guo, Bin Wang, Jiming Zhang
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS pathogens 15 (4) (2019)
Hong-Ying Guo, Beidi Zhu, Shu Li, Jing Li, Zhiqing Shen, Yijuan Zheng, Weidong Zhao, Dan Tan, Jingwen Wu, Xueyun Zhang, Qirong Jiang, Xun Qi, Richeng Mao, Xue-Ping Yu, Zhijun Su, Ji-Ming Zhang
Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. BioMed research international 2019 (2019)

Xue-Ping Yu.css-eqlu8i{font-size:small;padding-left:4px;} (Xueping Yu)

Publication Activity (10 Years)

Top Topics

Top Venues

Xue-Ping Yu (Xueping Yu)